Psylaris

Based in the Netherlands, Psylaris develops innovative digital solutions aimed at enhancing mental health care through virtual reality therapy and EMDR interventions for therapists worldwide. Psylaris, founded in 2017 and headquartered in Maastricht, Netherlands, specializes in mental health technology solutions. The company has recently focused on expanding its product offerings and improving accessibility for mental health professionals. It has completed one funding deal as of October 2025, raising an undisclosed amount from Brightlands Venture Partners (BVP), with participation from existing investors LIOF, INZET, and CbusineZ.

Psylaris delivers innovative digital solutions aimed at enhancing mental health care accessibility and efficiency. The company’s core offerings include advanced virtual reality (VR) therapy products and digital Eye Movement Desensitization and Reprocessing (EMDR) interventions, designed for use by therapists worldwide. These applications serve to streamline treatment processes, reduce waiting times, and facilitate both independent and guided client sessions. Psylaris' technology has been adopted by over 7,500 therapists globally, making it a trusted tool in addressing a variety of mental health conditions, such as anxiety disorders and trauma symptoms.

The company operates in multiple international markets, catering primarily to mental health professionals and institutions seeking to implement scalable and effective treatment solutions. Psylaris generates revenue through subscription-based models and partnerships with various mental health organizations. The business transactions typically involve therapists and clinics subscribing to their software, which includes flagship products like Psylaris Care, EMDR-plus, and EMDR-VR. These offerings are designed to provide a seamless experience for remote sessions, including real-time video consultations.

Pricing structures are tailored to accommodate different organizational needs, ensuring that therapists can access the tools necessary for effective treatment delivery. The company emphasizes its commitment to continuous development and support, reinforcing its value proposition within the mental health care sector. In October 2025, Psylaris raised an undisclosed amount in venture funding from Brightlands Venture Partners (BVP), with participation from returning investors LIOF, INZET, and CbusineZ. The company will use the funding to expand its activities across Western Europe, accelerate the development of next-generation VR therapies, and strengthen collaborations with mental health institutions.

Psylaris plans to launch new products aimed at enhancing therapy experiences and is targeting further growth in both local and international markets.